Sekisui Diagnostics Announces FDA Clearance and CLIA Waiver of the AcucyTM Influenza A&B Test

2019-10-07T15:44:27-07:00October 7th, 2019|

Burlington, MA – October 8, 2019 –Sekisui Diagnostics announces the Acucy Influenza A&B Test has received 510(k) clearance as a Class II assay from the US Food and Drug [...]


2018-11-15T10:24:39-08:00April 28th, 2017|

The SEKISUI OPEN will take place in the Sportpark Pilatus in Kriens, Switzerland from 16 to 21 May 2017. For the second time a PSA 5 women’s tournament will [...]

World Thrombosis Day – October 13

2018-11-15T09:39:38-08:00October 7th, 2015|

Think Venous Thromboembolism (VTE) 10 million cases of VTE are reported in Europe and US alone, leading to 1,600 deaths daily 1 in 4 people die from complications related to thrombosis, making it [...]

World Thrombosis Day

2018-11-15T08:52:39-08:00October 13th, 2014|

STOP BLOOD CLOTS, SAVE LIVES Thrombosis is the one disorder that causes the world's top three  cardiovascular killers. Heart attack, stroke, and venous thromboembolism (VTE) are the 3 leading [...]

Sekisui Diagnostics Launches New High Throughput Automated Coagulation System

2018-11-15T08:41:36-08:00January 2nd, 2014|

Lexington, MA– Sekisui Diagnostics announces the launch of the new CoaprestaTM 2000 (CP2000) Coagulation System in Europe, Middle East and Africa regions. The system will be available for purchase through [...]

Site Search

Search Products

Search Documents